Regulus Therapeutics
Regulus Therapeutics Logo
About Regulus Therapeutics
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel oligonucleotide therapeutics that inhibit dysregulated microRNA targets to treat genetically based orphan diseases. Its lead product candidate, RGLS8429, is an anti-miR oligonucleotide in Phase 1b clinical trials for autosomal dominant polycystic kidney disease (ADPKD). The company is also advancing a pipeline of preclinical drug candidates for organ-selective delivery. Regulus Therapeutics was founded in 2007 and operates in the United States.
Address
4224 Campus Point Court, Suite 210
San Diego, 92121
United States
Year founded
2007
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
